Utrecht, Netherlands

Patrick Priem

USPTO Granted Patents = 2 


Average Co-Inventor Count = 13.0

ph-index = 2

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Patrick Priem: Innovator in Heterodimeric Protein Production

Introduction

Patrick Priem is a notable inventor based in Utrecht, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the production of heterodimeric proteins. With a total of two patents to his name, Priem's work is recognized for its innovative approach and potential applications in various industries.

Latest Patents

Priem's latest patents focus on the production of heterodimeric proteins. The first patent describes an in vitro method for producing these proteins, which are essential for various biological functions and therapeutic applications. This invention aims to enhance the efficiency and effectiveness of protein production processes.

Career Highlights

Patrick Priem is currently associated with Genmab AS, a leading biotechnology company known for its focus on developing differentiated antibody therapeutics for the treatment of cancer. His role at Genmab allows him to leverage his expertise in protein production to contribute to groundbreaking research and development efforts.

Collaborations

Throughout his career, Priem has collaborated with esteemed colleagues, including Michael J. Gramer and Amitava Kundu. These collaborations have fostered a dynamic exchange of ideas and expertise, further enhancing the impact of his work in the field.

Conclusion

In summary, Patrick Priem is a distinguished inventor whose work in the production of heterodimeric proteins has the potential to advance biotechnology significantly. His contributions, along with his collaborations at Genmab AS, position him as a key figure in the ongoing innovation within the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…